Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threatening.

• Authors: VYSKOČIL Jiří; TUČEK Štěpán; KISS Igor; FĚDOROVÁ Lenka; NEVRLKA Jiří; ZDRAZILOVA-DUBSKA L
• Year of publication: 2019
• Type: Article in Periodical
• Magazine / Source: International Immunopharmacology
• Web: http://dx.doi.org/10.1016/j.intimp.2019.105728.Epub2019Jul6.
• Doi: http://dx.doi.org/10.1016/j.intimp.2019.105728.Epub2019Jul6.